Antimetabolites: all 7,479 studies that test it

Page 24 of 75. Open to participants first (1,134), then studies with results posted, then the rest; newest registration first within each.

• Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by SurgeryCompletedNCT00777491Phase 2Results posted
• Allogeneic Transplantation For Severe OsteopetrosisCompletedNCT00775931Phase 2/3Results posted
• Clofarabine and Temsirolimus in Treating Older Patients With Relapsed or Refractory Acute Myeloid LeukemiaCompletedNCT00775593Phase 2Results posted
• High-dose Cytarabine/Mitoxantrone Followed by Autotransplantation for t-MDS/t-AMLCompletedNCT00774046Phase 2Results posted
• Phase III Study of S-1 + Cisplatin vs Cisplatin in Cervical CancerCompletedNCT00770874Phase 3Results posted
• A Rheumatoid Arthritis Study to Assess Early Response to Abatacept+MTX as Defined by Improvement of Synovitis Measures by Power Doppler UltrasonographyCompletedNCT00767325Phase 3Results posted
• Combination 5-azacitidine and Gemtuzumab Ozogamicin Therapy for Treatment of Relapsed Acute Myeloid Leukemia (AML)CompletedNCT00766116Phase 1/2Results posted
• Vorinostat, Cladribine, and Rituximab in Treating Patients With Mantle Cell Lymphoma, Relapsed Chronic Lymphocytic Leukemia, or Relapsed B Cell Non-Hodgkin's LymphomaCompletedNCT00764517Phase 2Results posted
• A Study of Pemetrexed, Carboplatin and Bevacizumab in Participants With Nonsquamous Non-Small Cell Lung CancerCompletedNCT00762034Phase 3Results posted
• Study of Low-Dose Fractionated Radiotherapy in Patients With Locally Advanced Metastatic Pancreatic CancerCompletedNCT00761345Phase 1Results posted
• Trial of Decitabine in Patients With Acute Myelogenous Leukemia or Myelodysplastic SyndromeCompletedNCT00760084Phase 2Results posted
• METhotrexate Therapy Effects in the Physical Capacity of Patients With ISchemic Heart Failure (METIS Trial)CompletedNCT00759811Phase 2/3Results posted
• Identifying Prognostic Factors in Frontline FCR for Patients With Chronic Lymphocytic Leukemia (CLL)CompletedNCT00759798Phase 2Results posted
• D-Cycloserine Facilitation of Cocaine - Cue ExtinctionCompletedNCT00759473Phase 2Results posted
• A Randomized Phase 2 Pharmacokinetic Trial of Chemotherapy With or Without Panitumumab in Patients With Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and NeckCompletedNCT00756444Phase 2Results posted
• A Study to Assess the Effect of Tocilizumab Plus Methotrexate on Safety and Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid ArthritisCompletedNCT00754572Phase 3Results posted
• Vandetanib Gemcitabine Or Placebo Plus Gemcitabine Or Vandetanib Monotherapy In Advanced Biliary Tract CancerCompletedNCT00753675Phase 2Results posted
• A Phase I/II Clinical Trial of Vidaza With Abraxane in Patients With Advanced/Metastatic Solid Tumors and Breast CancerCompletedNCT00748553Phase 1/2Results posted
• An Efficacy and Safety Study of Decitabine in Participants With Myelodysplastic Syndrome (MDS)CompletedNCT00744757Phase 2Results posted
• Bortezomib, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid LeukemiaCompletedNCT00742625Phase 1/2Results posted
• Using D-cycloserine to Enhance the Benefits of Cognitive Behavioral Therapy for SchizophreniaCompletedNCT00742079Phase 4Results posted
• Chemotherapy Followed by Allogeneic Stem Cell Transplantation for Hematologic MalignanciesCompletedNCT00741455Not applicableResults posted
• Study Evaluating The Combination Of Neratinib And Capecitabine In Solid Tumors And Breast CancerCompletedNCT00741260Phase 1/2Results posted
• Pemetrexed Disodium or Erlotinib Hydrochloride as Second-Line Therapy in Treating Patients With Advanced Non-small Cell Lung CancerTerminatedNCT00738881Phase 3Results posted
• An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural MesotheliomaCompletedNCT00738582Phase 2Results posted
• Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ AdenocarcinomaCompletedNCT00737438Phase 2Results posted
• Phase II Study of TAS-106 to Treat Head and Neck CancerTerminatedNCT00737360Phase 2Results posted
• Trial of 2 Cycles of Induction Chemo With Abraxane, Cetuximab, Cisplatin, & 5-FU for Advanced Head and Neck CancerCompletedNCT00736944Phase 2Results posted
• Trial Of AG-013736, Cisplatin, And Gemcitabine For Patients With Squamous Non-Small Cell Lung CancerCompletedNCT00735904Phase 2Results posted
• Gemcitabine and Erlotinib Before and After Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by SurgeryCompletedNCT00733746Phase 2Results posted
• A Safety Study Of Sunitinib In Combination With Pemetrexed In Patients With Advanced Solid MalignanciesCompletedNCT00732992Phase 1Results posted
• A Trial of Anti-TNF Chimeric Monoclonal Antibody (cA2) in Korean Patients With Active Rheumatoid Arthritis Despite Methorexate (Extension Part)(Study P05645)(COMPLETED)CompletedNCT00732875Phase 3Results posted
• Pemetrexed and Radiation for Poor-Risk Stage III Non-Small Cell Lung CancerTerminatedNCT00732303Phase 2Results posted
• Allopurinol Maintenance Study for Bipolar DisorderTerminatedNCT00732251Phase 4Results posted
• Lenalidomide, Fludarabine & Cyclophosphamide in Advanced Chronic Lymphocytic Leukemia Not Responding to TherapyCompletedNCT00727415Phase 1/2Results posted
• Oral Cladribine in Early Multiple Sclerosis (MS)CompletedNCT00725985Phase 3Results posted
• Clofarabine Bone Marrow CytoreductionCompletedNCT00724009Phase 2Results posted
• Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic CancerCompletedNCT00723099Phase 2Results posted
• Study of Pralatrexate to Treat Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary BladderCompletedNCT00722553Phase 2Results posted
• Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast CancerCompletedNCT00721630Phase 2Results posted
• Docetaxel, Cisplatin, and Fluorouracil Followed By Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck CancerCompletedNCT00721513Phase 2Results posted
• 5-Azacytidine Prior to Allogeneic Stem Cell Transplant in High Risk Myelodysplastic SyndromeCompletedNCT00721214Phase 2Results posted
• A Study to Assess the Effect of Maintenance Treatment With Rituximab Versus No Treatment in Participants With Progressive B-Cell Chronic Lymphocytic Leukemia (CLL)CompletedNCT00718549Phase 3Results posted
• Study of Capecitabine to Treat Recurrent High Grade GliomasCompletedNCT00717197Phase 2Results posted
• Combination of Decitabine and Temozolomide in the Treatment of Patients With Metastatic MelanomaCompletedNCT00715793Phase 1/2Results posted
• Gemcitabine and Split-dose Cisplatin (GC) Plus Sorafenib in Chemotherapy-naïve Patients With Locally Advanced or Metastatic Urothelial CarcinomaTerminatedNCT00714948Phase 2Results posted
• Non-Myeloablative Allogeneic HSCT From HLA Matched Related or Unrelated Donors for the Treatment of Low Grade B Cell MalignanciesTerminatedNCT00714259Phase 2/3Results posted
• Docetaxel, Oxaliplatin, and Fluorouracil in Treating Patients With Metastatic or Unresectable Stomach Cancer, Gastroesophageal Junction Cancer, or Other Solid TumorCompletedNCT00711243Phase 1/2Results posted
• Low-dose Oral Clofarabine for the Treatment of IPSS INT-1, INT-2 or HIGH Myelodysplastic Syndromes and Chronic Myelomonocytic LeukemiaTerminatedNCT00708721Phase 1/2Results posted
• Docetaxel, Cisplatin and Fluorouracil in Treating Patients With Previously Untreated Stage II-IV Nasal Cavity and Paranasal Sinus CancerTerminatedNCT00707473Phase 2Results posted
• Combination of Hydroxyurea and Verapamil for Refractory MeningiomasCompletedNCT00706810Phase 2Results posted
• Study of CGC-11047 When Used in Individual Combinations With 1) Gemcitabine or 2) Docetaxel or 3) Bevacizumab or 4) Erlotinib or 5) Cisplatin or 6) 5-Flurouracil or 7) Sunitinib in Patients With Advanced Solid Tumors or LymphomaCompletedNCT00705874Phase 1Results posted
• Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid LeukemiaCompletedNCT00703820Phase 3Results posted
• Alimta® Plus Cisplatin & Paclitaxel Given Intraperitonelly; First Line Tx Stage III Ovarian CancerCompletedNCT00702299Phase 1Results posted
• A Study of First Line Treatment With Tarceva (Erlotinib) in Combination With Gemcitabine in Patients With Unresectable Advanced and/or Metastatic Non-Small Cell Lung CancerCompletedNCT00701558Phase 2Results posted
• Study of CBP501 + Pemetrexed + Cisplatin on MPM (Phase I/II)CompletedNCT00700336Phase 1/2Results posted
• Clofarabine for Myelodysplastic Syndrome (MDS) Patients Who Failed Vidaza Treatment (tx)TerminatedNCT00700011Phase 2Results posted
• Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerCompletedNCT00698815Phase 2Results posted
• Study of Gemcitabine and Erlotinib Plus Sorafenib (GES) in Metastatic Pancreatic CancerCompletedNCT00696696Phase 2Results posted
• Measuring Adherence To Topical 5-Fluorouracil in a Clinic PopulationCompletedNCT00696488Phase 4Results posted
• Yttrium-90 Ibritumomab Tiuxetan Plus High-Dose BEAM Followed By ASCT For Relapsed B-Cell Non-Hodgkin LymphomaCompletedNCT00695409Phase 2Results posted
• Methotrexate Polyglutamate Levels as a Marker for the Clinical Outcome in the Treatment of Rheumatoid ArthritisCompletedNCT00695188Phase 4Results posted
• LBH589 Plus Decitabine for Myelodysplastic Syndromes (MDS) or Acute Myeloid Leukemia (AML)CompletedNCT00691938Phase 1/2Results posted
• Clofarabine and Rituximab in Treating Patients With Relapsed Non-Hodgkin LymphomaTerminatedNCT00691652Phase 1/2Results posted
• Efficacy and Safety of Etanercept in Active RA Despite Methotrexate Therapy in JapanCompletedNCT00688103Phase 4Results posted
• Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung CancerCompletedNCT00686959Phase 3Results posted
• S0713: Oxaliplatin, Capecitabine, Cetuximab, and RT Followed By Surgery in Pts W/Stage II or III Rectal CancerCompletedNCT00686166Phase 2Results posted
• Reduced Intensity Transplant in Medically Refractory Systemic Lupus Erythematosus (SLE) and Systemic Sclerosis (SSc)TerminatedNCT00684255Phase 1Results posted
• T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic MalignanciesCompletedNCT00683046Phase 2Results posted
• Chemotherapy & Bevacizumab for Human Epidermal Growth Factor Receptor 2 (HER2)/Neu-Negative Stage II/III Breast CancerTerminatedNCT00679029Phase 2Results posted
• Veteran Stress and Learning StudyCompletedNCT00674570Phase 4Results posted
• A Phase II Trial of Gemcitabine and Oxaliplatin for Triple Negative Metastatic Breast CancerTerminatedNCT00674206Phase 2Results posted
• Perioperative Panitumumab and Epirubicin, Oxaliplatin and Xeloda (EOX) in Patients With Gastroesophageal AdenocarcinomaTerminatedNCT00667420Phase 1/2Results posted
• Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by SurgeryTerminatedNCT00665457Phase 2Results posted
• Cetuximab and Combination Chemotherapy in Patients With Stage III-IV Resectable Oropharynx CancerCompletedNCT00665392Phase 2Results posted
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast CancerCompletedNCT00662129Phase 2Results posted
• Study Of Sunitinib With Capecitabine In Breast CancerCompletedNCT00662025Phase 2Results posted
• Evaluating the Safety and Effectiveness of Decitabine in People With Thalassemia IntermediaCompletedNCT00661726Phase 2Results posted
• A Feasibility Phase II Study in the Treatment of Resected Cholangiocarcinoma, Gallbladder, Pancreatic and Ampullary CancersCompletedNCT00660699Phase 2Results posted
• Pre-Transplant 5-Azacitidine In Patients With High-Risk Myelodysplastic Syndrome Who Are Candidates For Allogeneic Hematopoietic Cell TransplantCompletedNCT00660400Not applicableResults posted
• Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid LeukemiaActive, not recruitingNCT00658814Phase 2Results posted
• Phase II Study of Idarubicin, Cytarabine, and Vorinostat With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)CompletedNCT00656617Phase 2Results posted
• Ph2 Gem/Nov/Rituxan Rel/Ref MantleCellCompletedNCT00656084Phase 2Results posted
• CAMEO: Canadian Methotrexate and Etanercept Outcome StudyCompletedNCT00654368Phase 4Results posted
• Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid/Rhabdoid Tumor of the Central Nervous SystemCompletedNCT00653068Phase 3Results posted
• Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal FunctionCompletedNCT00652626Phase 1Results posted
• Phase 2 Study of S-1 in Advanced or Metastatic Pancreatic CancerCompletedNCT00651742Phase 2Results posted
• Combined Treatment of Methotrexate + Glucocorticoids Versus Glucocorticoids Alone in Patients With PM and DMCompletedNCT00651040Phase 3Results posted
• A Dose Escalation Study of Adavosertib (MK-1775) in Combination With Either Gemcitabine, Cisplatin, or Carboplatin in Adults With Advanced Solid Tumors (MK-1775-001)CompletedNCT00648648Phase 1Results posted
• Hepatic Arterial Infusion of Floxuridine, Gemcitabine Hydrochloride, and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer Previously Treated With SurgeryCompletedNCT00645710Phase 1/2Results posted
• Oral Clofarabine for Relapsed/Refractory Non-Hodgkin LymphomaCompletedNCT00644189Phase 1/2Results posted
• Allopurinol Add-on Treatment for Refractory ManiaCompletedNCT00643123Phase 4Results posted
• CLARITY Extension StudyCompletedNCT00641537Phase 3Results posted
• Reduced Intensity AlloTransplant For OsteopetrosisTerminatedNCT00638820Phase 2Results posted
• Glycine and Oral D-Cycloserine in Alcoholic Patients and Healthy SubjectsCompletedNCT00635102Not applicableResults posted
• CO07204-Phase I/II of Oxaliplatin, Capecitabine & Sorafenib for Advanced Pancreatic & Biliary CarcinomaCompletedNCT00634751Phase 1/2Results posted
• Open-label Leucovorin Pharmacokinetic Study in Patients Receiving High Dose Methotrexate With or Without VoraxazeCompletedNCT00634504Phase 1Results posted
• Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaCompletedNCT00634244Phase 2Results posted
• Phase I Study of Ixabepilone Plus Lapatinib With or Without Capecitabine in the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast CancerTerminatedNCT00634088Phase 1Results posted
• D-Cycloserine Enhancement of Exposure in Social PhobiaCompletedNCT00633984Phase 4Results posted

← Antimetabolites overview